Mississippi Delta Community Care Home Visits Program

by palligoelme@gmail.com | Jun 5, 2025 | Clinical Trials

​ Conditions: Maternal Behavior; Postpartum Mood Disturbance Interventions: Behavioral: The PEN-3 Intervention Model Sponsors: Jackson State University; Mississippi State Department of Health; University of Mississippi Medical Center; Harvard School of Public Health...

Diagnostic Performance of the CandID PLUS PCR for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients

by palligoelme@gmail.com | Jun 5, 2025 | Clinical Trials

​ Conditions: Intra-Abdominal Infection; Candida; Peritonitis Infectious; Molecular Diagnostic; Critically Ill Intensive Care Unit Patients Sponsors: Central Hospital, Nancy, France Completed Conditions: Intra-Abdominal Infection; Candida; Peritonitis Infectious;...

Perspectives of Italian Employers Regarding the Return to Work Process of Employees Who Received a Cancer Diagnosis: a Qualitative Study

by palligoelme@gmail.com | Jun 5, 2025 | Clinical Trials

​ Conditions: Cancer Survivors Sponsors: Azienda USL Reggio Emilia – IRCCS; Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) Not yet recruiting Conditions: Cancer Survivors Sponsors: Azienda USL Reggio Emilia – IRCCS;...

Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education

by palligoelme@gmail.com | Jun 5, 2025 | Clinical Trials

​ Conditions: Stage I Colorectal Cancer AJCC v8; Stage II Colorectal Cancer AJCC v8; Stage III Colorectal Cancer AJCC v8 Interventions: Other: Educational Intervention; Other: Electronic Health Record Review; Other: Internet-Based Intervention; Behavioral: Patient...

A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight

by palligoelme@gmail.com | Jun 4, 2025 | Clinical Trials

​ Conditions: Diabetes Mellitus, Type 2; Obesity Interventions: Drug: NNC0519-0130; Drug: Placebo Sponsors: Novo Nordisk A/S Not yet recruiting Conditions: Diabetes Mellitus, Type 2; Obesity Interventions: Drug: NNC0519-0130; Drug: Placebo Sponsors: Novo Nordisk A/S...